Scie-Plas puts a new spin on mini centrifuges

Published: 14-Sep-2010
Manufacturing

Compact model is fitted with three rotors for bioscience research use

Scie-Plas puts a new spin on mini centrifuges
The first mini centrifuge to be launched by Scie-Plas is a compact, economical model supplied with three rotors for use in a range of bioscience research applications.

The Cambridge, UK and Holliston, MA, US-based firm says the product is easy to use. It features an on/off switch that allows the lid to be closed without starting the unit and when the lid is opened, the centrifuge stops automatically.

The three rotors include a 6-place rotor for 1.5ml tubes, a 0.2ml PCR strip rotor, and a 1x3in slide rotor. A maximum speed of 6,000rpm/2,000 x g is perfect for quickly spinning down samples, in micro gel filtration applications and for micro-volume centrifugation, the company says.

John Attwood, director of sales and marketing at Scie-Plas, said: ‘The mini centrifuge has been developed to complement our wide range of electrophoresis reagents, buffers and equipment, from transilluminators and blotting units to gel documentation systems.

‘The new mini centrifuge is a highly versatile sample preparation tool for every laboratory bench.’

See more

You may also like

Manufacturing
Your checkweigher is now a GMP data system — are you treating it like one?

Your checkweigher is now a GMP data system — are you treating it like one?

Read more
The weighing mechanism may be familiar. The regulatory expectations around the data it creates are becoming much harder to ignore.

Trending Articles

  1. Sterling Pharma Solutions doubles ADC manufacturing capacity at Deeside with new GMP suite The multi-million-pound expansion adds a 1400 sqft Grade C cleanroom, OEB5 containment handling and a 3400 sqft analytical laboratory — extending Sterling's bioconjugation capability from development through to Phase III and commercial scale
  2. Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Why manufacturability needs a seat at the table earlier in drug development Chris Davison, CEO of Centrix Pharma, explains why considering manufacturability early in clinical development can reduce risk and support smoother progression to later-stage production
  4. Catalent launches ten-month gene-to-drug substance programme for complex biologics The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting master cell bank release by month seven and bulk drug substance lot release by month ten
  5. Hovione to install first ConsiGma CDC Flex continuous tableting line in US The CDMO is investing $35m in a next-generation continuous tableting line at its 89 Twin Rivers facility in New Jersey, creating an integrated US pathway from spray-dried amorphous solid dispersions to commercial tablet production

You may also like

Manufacturing
Your checkweigher is now a GMP data system — are you treating it like one?

Your checkweigher is now a GMP data system — are you treating it like one?

The weighing mechanism may be familiar. The regulatory expectations around the data it creates are becoming much harder to ignore.
Manufacturing
Step into cognitive manufacturing: Welcoming you to Booth S-1720

Step into cognitive manufacturing: Welcoming you to Booth S-1720

At Pack Expo 2026, IMA Group will showcase its latest innovations in processing, packaging, end-of-line, automation, as well as digital solutions and customer services across the Pharmaceutical, Med-Tech, Food, Personal Care, E-Commerce and Labeling industries
Manufacturing
Xelia and Hisun sign strategic global multiple-API partnership

Xelia and Hisun sign strategic global multiple-API partnership

Long-standing joint venture partners expand collaboration, moving beyond anti-infective APIs into diversified therapeutic areas, including cardiovascular and oncology
Manufacturing
Patented device reinvents Solid Phase Extraction

Patented device reinvents Solid Phase Extraction

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Manufacturing
Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
Manufacturing
Lonza advances aseptic spray drying for high-dose biologics

Lonza advances aseptic spray drying for high-dose biologics

This new technology platform addresses stability, concentration, and delivery challenges in biologics, including new modalities
Manufacturing
Catalent launches ten-month gene-to-drug substance programme for complex biologics

Catalent launches ten-month gene-to-drug substance programme for complex biologics

The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting master cell bank release by month seven and bulk drug substance lot release by month ten
Subscribe now